Jiri Neuzil

A peptide conjugate of Vitamin E succinate targets breast cancer cells with high erbB2 expression (2007)

Wang, Xiufang, Birringer, Marc, Dong, Lan-feng, Veprek, Pavel, Low, Pauline, Cowie, Emma Angela, ...

Overexpression of erbB2 is associated with resistance to apoptosis. We explored whether high level of erbB2 expression by cancer cells allows their targeting using an erbB2-binding peptide (LTVSPWY)...

Vitamin E analogs, a novel group of "Mitocans," as anticancer agents: The importance of being redox-silent (2007)

Neuzil, Jiri, Tomasetti, Marco, Zhao, Yan, Dong, Lan-feng, Birringer, Marc, Wang, Xiufang, ...

The search for a selective and efficient anticancer agent for treating all neoplastic disease has yet to deliver a universally suitable compound(s). The majority of established anticancer drugs...

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II (2007)

Neuzil, Jiri, Dyason, Jeffrey Clifford, Freeman, Ruth, Dong, Lan-feng, Prochazka, Lubomir, Wang, Xiufang, ...

Recently mitochondria in cancer cells have emerged as the Achilles heel for tumour destruction. Anti-cancer agents specifically targeting cancer cell mitochondria are referred to as 'mitocans'. These...

α-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling (2007)

Neuzil, Jiri, Cowie, Emma Angela, Wang, Xiufang, Dong, Lan-feng, Stapelberg, Michael

Malignant mesothelioma (MM) cells enhanced proliferation of endothelial cells (ECs) as well as their angiogenesis in vitro by secretion of fibroblast growth factor-2 (FGF2). This effect was...

Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)

Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...

Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...

Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria (2007)

Neuzil, Jiri, Dong, Lan-feng, Ramanathapuram, Lalitha, Hahn, Tobias, Chladova, Miroslava, Wang, Xiufang, ...

Mitochondria have recently emerged as new and promising targets for cancer prevention and therapy. One of the reasons for this is that mitochondria are instrumental to many types of cell death and...

Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress (2007)

Dong, Lan-feng, Cowie, Emma Angela, Eliasson, Johanna Maria, Wang, Xiufang, Gold, Mikhal, Medunic, Yasmine, ...

''Mitocans'' from the vitamin E group of selective anticancer drugs, A-tocopheryl succinate (A-TOS) and its ether analogue A-TEA, triggered apoptosis in proliferating but not arrested endothelial...

α-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling (2007)

Neuzil, Jiri, Cowie, Emma Angela, Wang, Xiufang, Dong, Lan-feng, Stapelberg, Michael

Malignant mesothelioma (MM) cells enhanced proliferation of endothelial cells (ECs) as well as their angiogenesis in vitro by secretion of fibroblast growth factor-2 (FGF2). This effect was...

Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)

Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...

Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...

Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)

Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...

Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...

a-Tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: Potential therapy of malignancies of the nervous system? (2005)

Swettenham, Emma Angela, Whiting, Paul K., Salvatore, Brian A., Neuzil, Jiri

Vitamin E (VE) analogues, epitomized by ±-tocopheryl succinate (±-TOS), are potent inducers of apoptosis and anti-cancer agents. Here, we tested their effect on the highly malignant N-type...

a-Tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: Potential therapy of malignancies of the nervous system? (2005)

Swettenham, Emma Angela, Whiting, Paul K., Salvatore, Brian A., Neuzil, Jiri

Vitamin E (VE) analogues, epitomized by ±-tocopheryl succinate (±-TOS), are potent inducers of apoptosis and anti-cancer agents. Here, we tested their effect on the highly malignant N-type...

a-Tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: Potential therapy of malignancies of the nervous system? (2005)

Swettenham, Emma Angela, Whiting, Paul K., Salvatore, Brian A., Neuzil, Jiri

Vitamin E (VE) analogues, epitomized by ±-tocopheryl succinate (±-TOS), are potent inducers of apoptosis and anti-cancer agents. Here, we tested their effect on the highly malignant N-type...

Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way (2004)

Jostarndt, K., Rubic, T., Kuhn, H., Anthonsen, M.W., Andera, L., Gellert, Nina, ...

Peroxisome proliferator-activated receptor-³ (PPAR³) has been suggested to upregulate CD36. Since free oxidized polyunsaturated fatty acids are PPAR³ ligands, we studied the effects of LDL...

Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way (2004)

Jostarndt, K., Rubic, T., Kuhn, H., Anthonsen, M.W., Andera, L., Gellert, Nina, ...

Peroxisome proliferator-activated receptor-³ (PPAR³) has been suggested to upregulate CD36. Since free oxidized polyunsaturated fatty acids are PPAR³ ligands, we studied the effects of LDL...